| 2026-05-18 |
详情>>
内部人交易：
Galloway Heath H股份减少1822.00股
|
| 2026-05-11 |
详情>>
股本变动：
变动后总股本7658.37万股
变动原因 ▼▲
- 原因：
- From December 31,2025 to March 31,2026
Share-based compensation expense, exercises and other
|
| 2026-05-11 |
详情>>
业绩披露：
2026年一季报每股收益-0.08美元,归母净利润-646.8万美元,同比去年增长74.11%
|
| 2026-05-11 |
财报披露：
美东时间 2026-05-11 盘前发布财报
|
| 2026-04-02 |
股东大会：
将于2026-05-14召开股东大会
会议内容 ▼▲
- 1.To elect as directors the six nominees named in the accompanying Proxy Statement, each for a one-year term and until their respective successors are elected and qualified.
2.To ratify the appointment of KPMG LLP as Accendra Health’s independent registered public accounting firm for the year ending December 31, 2026.
3.To conduct a non-binding advisory vote on the compensation of Accendra Health’s named executive officers.
4.To approve the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan.
|
| 2026-02-20 |
详情>>
业绩披露：
2025年年报每股收益-14.31美元,归母净利润-11.01亿美元,同比去年增长-203.47%
|
| 2026-02-20 |
详情>>
业绩披露：
2023年年报每股收益-0.54美元,归母净利润-4130.1万美元,同比去年增长-284.47%
|
| 2025-10-31 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-13.55美元,归母净利润-10.44亿美元,同比去年增长-1468.75%
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益-11.6美元,归母净利润-8.94亿美元,同比去年增长-1561.82%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.32美元,归母净利润-2498.2万美元,同比去年增长-14.15%
|
| 2025-04-04 |
股东大会：
将于2025-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025;
3.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
4.To transact any other business properly before the Annual Meeting.
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益-4.73美元,归母净利润-3.63亿美元,同比去年增长-778.15%
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益0.30美元,归母净利润2238.90万美元,同比去年增长-89.9%
|
| 2025-02-04 |
复牌提示：
2025-02-03 15:30:33 停牌，复牌日期 2025-02-03 15:36:27
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.87美元,归母净利润-6657万美元,同比去年增长-12.67%
|
| 2024-08-02 |
详情>>
业绩披露：
2024年中报每股收益-0.7美元,归母净利润-5379.9万美元,同比去年增长-2.16%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益-0.29美元,归母净利润-2188.6万美元,同比去年增长10.37%
|
| 2024-03-27 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve the amendment to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan;
4.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
5.To transact any other business properly before the Annual Meeting.
|
| 2023-03-29 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To approve the Owens & Minor, Inc. 2023 Omnibus Incentive Plan;
3.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
4.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
5.To transact any other business properly before the Annual Meeting.
|
| 2022-03-17 |
股东大会：
将于2022-04-29召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022;
3.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
4.To conduct an advisory vote on the frequency of a shareholder vote on the compensation of our named executive officers;
5.To transact any other business properly before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-17 |
股东大会：
将于2021-04-29召开股东大会
会议内容 ▼▲
- 1.To elect the eight directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021;
3.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
4.To transact any other business properly before the Annual Meeting.
|
| 2020-03-19 |
股东大会：
将于2020-05-01召开股东大会
会议内容 ▼▲
- 1.To elect the eight directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To approve the amendment to the Owens & Minor, Inc. 2018 Stock Incentive Plan;
3.To approve the Owens & Minor, Inc. 2021 Teammate Stock Purchase Plan;
4.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020;
5.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
6.To transact any other business properly before the annual meeting.
|
| 2019-03-28 |
股东大会：
将于2019-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the attached Proxy Statement, each for a one-year term and until their respective successors are elected and qualified;
2.To approve an amendment to the Owens & Minor, Inc. 2018 Stock Incentive Plan;
3.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019;
4.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
5.To vote on a shareholder proposal, if properly presented at the annual meeting;
6.To transact any other business properly before the annual meeting.
|
| 2018-03-26 |
股东大会：
将于2018-05-08召开股东大会
会议内容 ▼▲
- 1.To elect the 10 directors named in the attached proxy statement, each for a one-year term and until their respective successors are elected and qualified;
2.To approve the Owens & Minor, Inc. 2018 Stock Incentive Plan;
3.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018;
4.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
5.To transact any other business properly before the annual meeting.
|
| 2017-03-22 |
股东大会：
将于2017-05-05召开股东大会
会议内容 ▼▲
- 1.To elect the 11 directors named in the attached proxy statement, each for a one-year term and until their respective successors are elected and qualified;
2.To approve the proposed Owens & Minor, Inc. 2017 Teammate Stock Purchase Plan;
3.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2017;
4.To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
5.To transact any other business properly before the annual meeting.
|
| 2011-04-15 |
除权日：
美东时间 2011-04-26 每股派息0.04美元
|